BioCurex, Inc.(fka BOCX)

[HALF FULL GLASS]

I find this interesting. How much of these costs will be covered by Abbott...

Biocurex anticipates that the capital requirements for the year ended December 31, 2005 will be as follows:




Research and Development - Theraputics $ 400,000
Research and Development - Histo-Recaf kits 75,000
Research and Development - Serum screening assay 250,000
Research and Development - Imagery 200,000
Payment of Outstanding Liabilities 420,000
General and Administrative Expenses 320,000
Marketing and Investor Communications 200,000
------------
Total: $1,865,000
============